Reuters logo
BRIEF-Cytokinetics starts phase 1B clinical trial of CK-2127107 in elderly subjects
June 29, 2017 / 11:50 AM / 3 months ago

BRIEF-Cytokinetics starts phase 1B clinical trial of CK-2127107 in elderly subjects

June 29 (Reuters) - Cytokinetics Inc

* Cytokinetics announces start of phase 1B clinical trial of CK-2127107 in elderly subjects with limited mobility

* Cytokinetics Inc - clinical trial is expected to enroll at least 60 subjects in United States who are 70 to 89 years of age with limited mobility Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below